The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma-Reference-Cited by-同舟云学术

The XOR-IDH3α axis controls macrophage polarization in hepatocellular carcinoma

Published:2023-07 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Lu Yijun,Sun Qikai^ORCID,Guan Qifei,Zhang Zechuan,He Qifeng,He Jianbo,Ji Zetao,Tian Wenfang,Xu Xiaoliang,Liu Yang,Yin Yin,Zheng Chang,Lian Senlin,Xu Bing,Wang Pin,Jiang Runqiu,Sun Beicheng^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Epidemiology and management of hepatocellular carcinoma;Kulik;Gastroenterology,2019

3. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma;Llovet;Nat Rev Gastroenterol Hepatol,2021

4. Macrophages and metabolism in the tumor microenvironment;Vitale;Cell Metab,2019

5. Targeting macrophages: therapeutic approaches in cancer;Cassetta;Nat Rev Drug Discov,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring;Cellular & Molecular Immunology;2024-09-09

2. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review);International Journal of Oncology;2024-09-05

3. Role of ACSL4 in modulating farnesoid X receptor expression and M2 macrophage polarization in HBV‐induced hepatocellular carcinoma;MedComm;2024-09

4. Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy;Frontiers in Immunology;2024-08-07

5. PdZn/Co_SA‐NC Nanozymes with Highly Efficient SOD/CAT Activities for Treatment of Osteoarthritis via Regulating Immune Microenvironment;Advanced Functional Materials;2024-07-08